PeptiDream Competitors and Similar CompaniesClear all

PeptiDream's competitors and similar companies include UCB, Cipla and EMS Pharma.

	PeptiDream PeptiDream (ペプチドリーム) is a biopharmaceutical company specializing in drug discovery and development.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
Founding Date	Founding Date 2006	Founding Date 1928	Founding Date 1935	Founding Date 1964
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Kawasaki, JP HQ Tokyo, JP	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations BR HQ
Employees	Employees 736	Employees 9,052	Employees 27,764	Employees 12,7441% increase
Valuation ($)	Valuation ($) 2.4 b	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥18.5b (FY, 2025)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥9.2b (FY, 2025)	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit ¥9.3b (FY, 2025)	Gross profit €7.2b (FY, 2025)	Gross profit ₹195b (FY, 2026)	Gross profit N/A
Net income	Net income (¥3.7b) (FY, 2025)	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income N/A